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INTRODUCTION
Various biliary tract diseases can be found in
clinical practice such as gallstones e.g. cholelithiasis,
choledocholithiasis; infections e.g. cholecystitis,
cholangitis; tumors e.g. cholangiocarcinoma (CC),
gallbladder carcinoma; cystic disease; strictures etc.
Imaging is central to the investigation and diagnoses
of biliary tract disease. Upper abdominal pain,
jaundice and abnormal liver function test are common
sign and symptom of biliary tract diseases. Therefore
imaging of the biliary tract should be performed to make
an exact diagnosis of the disease.1
The symptom of jaundice is not specific nor is
the physical findings. Jaundice can be due to biliary or
non biliary disease. Liver function test only confirm
cholestases that can be biliary or non biliary origin.1
Common bile duct obstruction, for example from stones
and tumor, must be distinguished from intra-hepatic
cholestasis such as that caused by drugs. Non
invasive tests e.g. ultrasonography (US), computed
tomography (CT), biliary scintigraphy, magnetic
resonance imaging (MRI) scans provide important data
on which to choose more invasive and definitive
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ABSTRACT
Imaging is central to the investigation and diagnoses of biliary tract disease. Upper abdominal pain,
jaundice and abnormal liver function test are common symptoms and signs and imaging of the biliary
tract should be performed to make an exact diagnosis of the disease. There are many options in the field
of imaging from simple to more sophisticated examinations. Several imaging techniques are obsolete
namely oral cholecystography, Intravenous cholangiography and biliary scintigraphy, and should
therefore be omitted. These imaging techniques are expensive and we should choose one or two options.
Abdominal ultrasound is less expensive and can be performed rapidly without special preparation or
contrast agent. It is the imaging of choice in the initial evaluation to evaluate patients with
hepatopacreaticobiliary diseases. From the result of abdominal ultrasound examination we can choose
further the right imaging technique that can disclose the diagnoses of the disease.
Keywords: biliary tract, diseases, imaging
techniques e.g. endoscopic retrograde cholangiography
(ERCP), percutaneous transhepatic cholangiography
(PTC), endoscopic ultrasonography (EUS), liver
biopsy.Interventional endoscopy and radiology provide
an alternative therapeutic approach to surgery.
NON-INVASIVE DIAGNOSTIC PROCEDURES
Plain Film of the Abdomen
Diagnostic yield is low and this test is usually
omitted.1 However, it may reveal gallstones if it is
radioopaque, a calcified gallbladder, pancreatic
calcification or rarely the outline of a distended
gallbladder.1,2 Gas in the biliary tree (aerobilia) may
be seen after endoscopic sphincterotomy or
surgical bile duct/bowel anastomosis. However,
abdominal US/CT has been recognized as a more
 sensitive technique than abdominal plain films for
diagnosing biliary tract disease.2,3
Oral Cholecystography
Imaging of the gallbladder for cholelithiasis and its
complications has changed dramatically in recent
decades along with expansion of interventional
techniques related to the disease. Now superseded by
US as the primary investigation for suspected
cholelithiasis, because of greater sensitivity and with
availability of transabdominal US, oral cholecysto-
graphy is no longer performed routinely, and has
a limited role in anatomical and functional assessment
of the gallbladder.1,4,5 US and CT are faster and offer
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more accurate in diagnosing conditions of
the gallbladder.6 The media common use is sodium
ipodate (biloptin) and calcium ipodate (solubiloptin).
The contrast agent conjugated with glucuronic acid by
the liver and excreted in the bile. In the fasting patient
contrast entered the gallbladder if the cystic duct is
patent.
Three X-ray films are necessary, control, fasting
after contrast, and after gallbladder contraction by fat
stimulation or cholecystokinin the gallbladder is seen
in 85% of patients. The technique is not valuable if
the bilirubin is greater than twice the upper limit of
normal because of failure of efficient secretion of
contrast by the liver.
Biliary Scintigraphy
Hepatobiliary scintigraphy is performed following
intravenous administration of typically 3 to 5 mCi of
a 95 mTc labelled hydroxy imino-diacetic acid (HIDA)
compound and is cleared from the plasma by
hepatocellular organic anion transport and excreted in
the bile. Effective concentration in the bile duct is
achieved in patients with total serum bilirubin exceeding
20 mg/dL. Hepatobiliary scintigraphy is most frequently
used to evaluate the presence of acute cholecystitis,
reflected by mechanical or functional obstruction of
the cystic duct resulting in absence of gallbladder
visualization.7,8 In the presence of signs and symptoms
such as right upper quadrant tenderness, elevated white
blood cell count, fever and gall stones, wall thickening
on gallbladder sonography, non–visualization of
the gallbladder by 60 minutes has sensitivity and
specificity greater than 95% for the diagnosis of acute
cholecystitis.
HIDA can detect high grade biliary obstruction prior
to ductal dilatation. HIDA also aids in the diagnosis of
partial obstruction due to stone, biliary strictures and
sphincter Oddi obstruction. It can confirm biliary
leakage post cholecystectomy and hepatic
transplantation.8,9 In the early post operative period
among patients who received liver transplants from
living related donors, hepatobiliary scintigraphy which
is non-invasive is useful to assess the graft.10,11
Hepatobiliary scintigraphy also has the potential to
assess the graft function and predict the recipients
outcome.12 In biliary scintigraphy the resolution is much
less compared with other forms of bile duct visualization
and the role is therefore limitted.13
Ultrasonography
Abdominal ultrasonography (US) is the most
important screening investigation in all patients with
liver function test abnormality or cholestasis.1 US is
usually the initial imaging test performed to evaluate
patients with biliary obstruction.14 It is the imaging
method of choice in the initial evaluation of all suspected
gallbladder and biliary duct diseases.15 It is particularly
valuable  and is the recommended initial imaging test
in patients with acute right upper quadrant pain,
jaundice and possible acute cholecystitis, no prior
preparation is necessary and patients can be imaged
directly from the emergency room.15-17 US is highly
reliable in detecting tiny gallstones and is useful for
evaluating focal or diffuse abnormalities of
the gallbladder wall. The characteristic US findings of
gallstones are a highly reflective echo from
the anterior surface of the gallstone, mobility of
the gallstone on repositioning the patient, and marked
posterior acoustic shadowing. It is highly valuable in
differentiating jaundice, whether the jaundice is of
biliary origin or liver parenchyma origin by detecting
the dilatation of the bile duct. Sonography is also very
sensitive in detection mechanical obstruction although
less sensitive for detection of obstructing tumors
including pancreatic carcinoma and CC.15,18
The sensitivity and accuracy of US for extra hepatic
cholangiocarcinoma (ECC) diagnosis are 89% and
80-95%, respectively.19,20,21 On the other hand,
intra hepatic cholangicarcinoma (ICC) are difficult to
distinguish from other solid intra-hepatic masses as
they lack specific US features. The ability of US to
detect the dilated bile duct and the level of obstruction
and in some instances the cause of the obstruction,
makes it the technique of choice for evaluating
jaundiced patients.22
US is less expensive compared to CT and can be
performed rapidly without patient preparation or
contrast agent. For examining the gallbladder, the
examination should be performed 6 hours after fasting
which result in a distended gallbladder full of bile to
ensure adequate distention of the gallbladder to
visualize small stones and imaging the gallbladder wall.
US examination of the gallbladder and liver may
detect gallbladder polyps or carcinoma or congenital
biliary anomalies such as Caroli’s disease or
choledochal cysts. US can also detect the cause of
obstruction albeit with less accuracy. Bile duct stones
are harder to detect than gallstones, the difficulty
related to gas sometimes obscuring the distal duct and
the lack of echo free bile around impacted stones.23
Sonography is also the imaging procedure of choice
for biliary tract intervention, including cholecystostomia,
guidance for percutaneous transhepatic cholangio-
graphy and drainage of peribiliary abscesses.15
The use of contrast agent in ultrasonography improves
the diagnostic power of ultrasonography imaging.3 The
role of US in the characterisation of focal liver lesions
has been transformed with the introduction of specific
contrast media and the development of specialized
imaging techniques.23 Ultrasonography now can fully
characterized the enhancement pattern of hepatic
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lesions, similar to that achieved with contrast enhanced
multiphasic CT and MRI. Most US contrast agent are
intravenously injected microbubbles smaller than a red
blood cell and thus capable of passing through capillary
beds. US contrast agents are safe, well-tolerated and
have very few contraindications. Furthermore, real-
time evaluation of the vascularity of focal liver lesions
has become possible with the use of the newer
microbubble contrast agents.24 Contrast enhanced
ultrasonography (CEUS) clearly showed the presence/
absence of blood supply lesion and offered real-time
imaging of the microcirculation perfusions in
the lesions. It also offered useful information to
differentiate biliary tumors from stones, bile mud,
and/or blood clots. It distinctly displayed the size and
contour of the lesions as well as the infiltrated range,
depth, and the involved area.
Computed Tomography
The most common CT findings in cholecystitis are
gallbladder wall thickening (> 3 mm) and
cholelithiasis.5,6 Other findings include increased
attenuation of the bile (> 20 Hounsfield) and loss of
clear delineation of the gallbladder wall.
Increased attenuation in the adjacent hepatic
parenchyma is useful indicator of acute inflammation.
Air within the gallbladder wall or lumen is
pathognomonic of complicated cholecystitis. A low
attenuation halo around the gallbladder may indicate
edema or minimal fluid collection and is a useful clue
in differentiating complicated cholecystitis from
carcinoma on CT scan. In the hands of the
experienced, CT are accurate noninvasive methods
of imaging the common bile duct. This is particularly
true when there is a low clinical and laboratory
probability of a common bile duct stone being present.25
CT shows dilated bile ducts distinguishing obstructive
from non obstructive jaundice in 90% of cases, but as
a screening procedure it has no advantage over US.
To identify dilated bile ducts, an evaluation for
strictures or filling defects is necessary and it is best
performed with thin-section imaging. Smooth,
concentric short-segment strictures suggest benign
cause; while abrupt, eccentric long-segment strictures
indicate a malignancy.26
The sensitivity of CT in differentiating hepatocellular
carcinoma from obstructive jaundice and in the level
and cause of obstruction parallel that of US.
Hilar cholangiocarcinoma usually presents centrally
near the portal hepatis producing obstruction of the
main hepatic duct and intra hepatic branches.
For diagnosing and staging CC, a triple-phase CT
scan is frequently used since it gives valuable data
about local spread, vascular invasion, lymph node
involvement including the presence of distant
metastases.27,28,29 ICC usually appear as hypodense
lesions with irregular margins on the initial images of
CT scans with some degree of delayed venous phase
enhancement.33 Such characteristics have been
demonstrated to be associated with prognosis, i.e.
hyperattenuating CC is more aggressive.34 ICC on CT
findings may be presented as dilating and thickening
of peripheral intra-hepatic bile ducts with retraction of
liver capsule.30 In contrast, ECC may appear as a
focal thickening of the ductal wall with numerous
enhancement patterns.35 Nevertheless, in many ECC
cases, neoplasm is not clearly visualize since their size
is too small to be noticed.
The reported CT sensitivity for common duct stone
detection varies from 45-90%.31 Non contrasts CT
may improve the recognition of choledocholithiasis to
more than 90%. The CT appearances of common duct
stones parallel that of gallstones and depend on the
chemical composition for each stone. Densely
calcified stone can be seen as high attenuation
structures within the duct lumen, but most duct stones
are iso-attenuating with soft tissue or bile on CT scan.
The coronal reconstruction of CT imaging did not
increase its diagnostic efficacy on choledocholithiasis.
The stone size affects the diagnostic rate of
abdominal CT for detecting choledocholithiasis.
The CT diagnostic rate was significantly lower in
patients with choledocholithiasis of less than 5 mm than
in patients with choledocholithiasis of 5 mm or more
(56.5 vs 81.2%).32
Imaging is most useful in evaluating for post-
transplantation complications, which are broadly
classified into vascular, biliary, and other complications.
Hepatic artery thrombosis is the most significant
complication and is often associated with graft failure.
When US findings are indeterminate or there is
persistent clinical suspicion for an abnormality, CT is
often performed. The major indications for CT are
detection of bile leak, hemorrhage, and abscess, but
CT is also useful in the assessment of the vasculature.
T-tube cholangiography and magnetic resonance
cholangiopancreatography (MRCP) are the best
noninvasive imaging tools for evaluating biliary
stricture.36
Magnetic Resonance Cholangiopancreatography
MRCP was first described by Walner et al, and is
a noninvasive method of imaging the biliary and
pancreatic ducts.37 The basic principle underlying
MRCP is that body fluids such as bile and pancreatic
secretions, have high signal intensify in heavily
T2-weighted magnetic resonance i.e. they appear
white, where as background tissues such as the
surrounding liver and flowing blood generated little
signal i.e. they appear dark. As a result of this
combination of imaging characteristics, MRCP
provides optimal contrast between the hyperintense
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signal of the bile and pancreatic secretions and
the hypointense signal of the background tissue (solid
organs), and blood vessels have no measurable signal.
On these images the intrinsic fluids of the biliary and
pancreatic ducts give the cholangiogram and
pancreatogram. MRCP is used with increasing
frequency as a non-invasive alternative to ERCP and
the diagnostic results are comparable with high
accuracy in various hepatobiliary pathologies.38
In most of patients with right upper quadrant or
epigastric pain with or without jaundice or jaundiced
patients with or without upper abdominal pain,
abdominal US and CT scan were mostly used as an
initial evaluation. In these cases the roadmap of the
biliary tract and the pancreatic duct is needed. The
next examination will be the choice of ERCP or
MRCP.39 If the complaint was due to biliary diseases
e.g. choledochal stone or stricture of the bile duct, it is
easy to find the dilatation of the bile duct on abdominal
US/CT; in these cases ERCP will be the choice
because it can be followed by therapeutic endoscopy
i.e. sphincterotomy and stone extraction, stent/
nasobiliary tube installment. The choice of imaging will
be ERCP when it is assumed that it will be followed
by therapeutic endoscopy. If the complaints were due
to parenchyma liver diseases there is no dilatation or
abnormality of the bile duct. In these cases it will not
be followed by therapeutic endoscopy and MRCP will
be the choice; hence unnecessary ERCP is here
avoided.40
No special patient preparation is required but
the usual contraindications to MRI scanning apply.37,40
Patients with cardiac pacemaker, neurostimulator,
ferromagnetic aneurism clips are excluded.
The examination is usually performed after fasting for
several hours. No sedation is required, no hospital
admittance is needed. In some patients claustrophobia
might be a problem.41 Oral contrast agent are not
administered, no intravenous contrast agents are
needed, and there is no radiation exposure.42 It is an
ideal imaging method for patients with allergies to ioded
based contrast or those with a general history of
atopy, and prevents the occurrence of contrast
nephropathy.31
MRCP is an alternative diagnostic technique for
the imaging of the bile tree and the pancreatic duct,
but it is not a therapeutic procedure.37 While ERCP is
used both for diagnosis and treatment, it has untoward
effects including mortality i.e. pancreatitis, bleeding
from sphincterotomy sites and duodenal perforation.43
MRCP is a non invasive tool that is suitable in
patients suspected to have pancreatic biliary diseases
where there is no likelihood or little possibility to
perform therapeutic intervention e.g. patients with
asymptomatic cholelithiasis without clinical evidence
of clinical bile duct disease like the presence of
jaundice and abnormalities of liver function test.
To identify dilated bile ducts, an evaluation for
strictures or filling defects is necessary and it is best
performed with thin-section imaging. Smooth,
concentric short-segment strictures suggest benign
cause; while abrupt, eccentric long-segment strictures
indicate a malignancy. When interpreting the MRI
results, caution should be made since the extrabiliary
entities such as crossing vessels or metallic clip
artifact which may mimic strictures should not be
misguided for disease.26 The most common biliary
filling defect is a stone that may arise without any
dilated ducts. It is usually found in a dependent portion
of the duct and usually has a lamellated geometric
shape. Any findings of bile duct wall thickening highly
suggest cholangitis or malignancy. Diagnosis of biliary
disease can be performed better when we have
knowledge about the advantages and limitations of
modern MR and CT cholangiographic techniques,
together with the use of biliary-excreted contrast
material and the numerous postprocessing
techniques.26
In evaluating bile duct and detecting stones in
the common bile duct MRCP is superior compared to
US and multi slice computed tomography (MSCT).44
Preoperative magnetic resonance cholangiography
(MRC) may hinder the need for intra operative
cholangiography (IOC). MRC has many benefits i.e.
reducing operative time and alleviating damage to
the common bile duct (CBD) that can occur during
IOC. It is also less invasive. Moreover, it can find
CBD stones pre-operatively and can help surgeon to
prepare save procedure. Routine pre-operative MRC
should be performed in patients with clinical or
biochemical findings indicating the possibility of CBD
stones.45
MRCP is especially useful in the clinical situations
as follow: (1) Screening of patients with abdominal
pain with less likehood of having choledochal stone. In
these situations unnecessary ERCP is avoided;40 (2)
Failed or incomplete ERCP;46 (3) Pre-operative MRC
should be done routinely in patients who clinical or
biochemical findings suggest the possibility of CBD
stones; (4) Post operative anatomy. MRCP has been
shown to be useful in demonstrating the bile ducts in
patients with surgically altered biliary anatomy such
as that associated with biliary-enteric anastomoses and
liver transplantation; (5) MRCP is a rapid and accurate
non invasive means of showing the presence of
intrahepatic stone and is more superior to ERCP for
the diagnosis of intra hepatic stone.47
The utility of MRCP in evaluating patients with CC
has been showed in numerous studies.48,49
Its diagnostic accuracy is comparable to invasive
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cholangiographic techniques, both ERCP and PTC.50-53
Thus, MRCP and MRI are considered to be the
radiological modality of choice for evaluating patients
with suspected CC.54 A hypointense lesion on MRCP,
i.e. on T1- and hyperintense on T2-weighted images
with pooling of contrast within the tumor on delayed
pictures as seen with CT may indicate ICC.55,56 While
ECC on MRCP may be seen as extrahepatic lesions
with similar signal intensity of ICC on both T1- and
T2-weighted images as well as proximal biliary
dilatation.48,55 Overall sensitivity of 88% and
specificity of 95% were demonstrated in a meta-
analysis of 67 studies (4,711 patients) evaluating MRCP
performance in patients with suspected biliary
diseases.49 Furthermore, another study demonstrated
that MRCP may predict the extent of biliary
ductal involvement in 96% cases of malignant hilar
obstruction.57
INVASIVE DIAGNOSTIC PROCEDURES
Intravenous Cholangiography
In intravenous cholangiography contrast material
injected intravenously was concentrated by the liver
so that hepatic and common bile ducts are
demonstrated. However this option had become
obsolete.1,5 Because its poor resolution compared to
ERCP, its poor diagnostic accuracy, its morbidity and
the advent of ERCP/MRCP and cannot be used if the
serum bilirubin level 2 mg% because the contrast
material will not be excreted to the bile duct,3 hence
there will be no cholangiogram, this technique is never
used again. Besides that, there is risk for allergy with
the use of intravenous contrast.
Intra Operative Cholangiography
Intra operative cholangiography (IOC) is
cholangiography that performs during surgical
procedure. The most common indication of IOC is
determination the need for exploration of CBD at the
time of cholecystectomy.1,58 Routine IOC is not
necessary at cholecystectomy unless there are
indications suggesting that stones are present in the
common bile duct.59 These include a history of
jaundice, dilated bile ducts, palpable gallstones or
a raised serum bilirubin, alkaline phosphatase or
gamma-glutamyl transpeptidase (G-GT) level.
IOC procedure can be performed at open or
laparoscopic cholecystectomy by inserting a catheter
intra operatively into the cystic duct. Afterward, an
injection of diluted (50%) contrast material is done to
have the outline of biliary tree. The presence of filling
defects, the anatomy and the calibre tree, and the flow
of contrast into the duodenum are detected by
assessing the films.
The positive predictive value of IOC findings for
detecting CBD stones is 60-75%. Such procedure may
fail because of (1) lack of ability to cannulate
the cystic duct; (2) leakage of contrast during
the injection; (3) the presence of air bubbles resembling
stones; (4) quick flowing of the contrast into
the duodenum, which prevents appropriate filling of
the biliary tree; (5) spasm of the sphincter of Oddi.
Following exploration of the bile duct, postoperative
cholangiography through a T-tube is suggested to
confirm that all stones have been removed.60
In patients who have no history of pancreatitis,
normal liver function test and CBD stone less than 10
mm diameter, laparoscopic cholecystectomy
performed without intra operative cholangiography
does not result in an increased incidence of retained
stone.61
Percutaneous Transhepatic Cholangiography
In percutaneous transhepatic cholangiography
(PTC) intrahepatic biliary duct is directly punctured
with fine flexible Chiba needle with the diameter
0.7 mm (22 Gauge), so that the patient still can normally
breath during the procedure.1 US is used as a guidance
in which the puncture was performed into the dilated
bile duct. This method is easy and will 100% success
if the bile duct is dilated.
PTC may be the modality of choice in whom ERCP
is difficult and failed due to the technical difficulties or
when ERCP is not possible to perform e.g. in patients
with hepaticoenterostomy, post Billroth II or in Klatskin
tumor. In patients with complete biliary obstruction,
ERCP often cannot assess the proximal biliary tree
while PTC cannot assess the distal extent of the
tumor.58
Complication occurred in 5-6.9%, consisted of
bleeding, bile peritonitis, cholangitis and sepsis, less
common were pneumothorax and puncture of
viscera.1,61 These complications can be reduced by
ensuring fastidious technique, with a single puncture
of the liver capsule, avoid over distention of ducts
which may allow reflux of infected bile to the
circulation through hepatic sinusoid, and ensuring that
maneuvers are carried out in suspended respiration.5
Uncorrected coagulopathy is a contraindication for
PTC, and the normal size of the intrahepatic duct
makes the procedure difficult. Prophylactic antibiotics
are recommended to reduce the risk of cholangitis.
Endoscopic Retrograde Cholangio Pancreatography
This method of direct cholangiography developed
in the year nineteen seventies.1,2 ERCP is a diagnostic
procedure to diagnose problem in the liver, gallbladder,
bile ducts and the pancreas, in which X-ray is
combined with the use of a flexible scope. With this
procedure papilla of Vater is searched endoscopically,
followed by canulation of the catheter and contrast
material is injected. This method needs high skill
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ability.
ERCP is performed to evaluate the liver, gallbladder,
bile duct and the pancreas to find out the etiology of
the abdominal pain or the unknown cause of jaundice.
From ERCP, the blockade and stone in the bile duct,
leakage of bile or pancreatic duct, pancreatic
obstruction or stenosis, the existence of tumor may be
found.
Complications that occurred were morbidity in
1-3%, mortality in 0.22%, and these were directly in
connection with skill and the experiences of
the operator and to the underlying biliary and pancreatic
diseases. The complications might occur are acute
pancreatitis, cholangitis, sepsis and duodenal
perforation or bleeding due to sphincterotomy and
biloma might occur (accumulation of biliary liquid
outside the biliary system).5 In pregnant women,
exposure to X-ray may result defect to the delivery,
and also there are patients that are allergy or sensitive
to the contrast material. ERCP procedure is
contraindicated in patients that had gastrointestinal
operation in the passed, and in patients with
esophageal diverticle or in patients with acute
pancreatitis. Although ERCP and PTC necessitate
invasive access to the biliary system but they can
provide dynamic images. Moreover, they can also
detect biliary abnormalities as well as determine
the location and extent of ECC within the biliary tree.
The selection between PTC and ERCP is usually
determined by the availability of local expertise and
the anatomical characteristics of the tumor.62 ERCP
often cannot assess the proximal biliary tree in
patients with complete biliary obstruction; while PTC
cannot assess the distal part of the tumor.58
The cholangiography sensitivity is 75-85% and
the specificity is 70-75% with accuracy of 95%.51,52,63
Endoscopic Ultrasonography
Endoscopic ultrasonography (EUS) is an established
diagnostic and therapeutic modality in gastroenterology
with increasing widespread use. EUS is done using an
endoscope which has a miniature ultrasonography
transducer on its tip. Most endoscope used for US has
mechanical rotating scanners at the tip and are side or
oblique viewing. The close proximity of the echo
endoscope to the extrahepatic bile duct system and its
safety make EUS an excellent method for examining
the common bile duct, gallbladder and adjacent
structures and for the detection and staging of
ampullary tumors, detection of microlithiasis and
choledocholithiasis and evaluation of benign and
malignant bile-duct strictures.64,65
EUS is at least as sensitivity as ERCP in detecting
stones and strictures.66,67 The sensitivity and accuracy
of EUS for choledocholithiasis is greater than 90%
and is more accurate than transabdominal
ultrasonography. EUS is also useful to look for tiny
bile duct stones.5  In patients with clinically suspected
biliary stone disease, without initial sonographic
documentation of choledocholithiasis , endoscopic
ultrasonography or magnetic resonance
cholangiopancreatography is the next logical imaging
step.15 Patient with choledocholithiasis demonstrated
a sensitivity for stone detection of 97% for EUS
compared with 25% for abdominal ultrasonography.68
EUS also demonstrated microlithiasis with a sensitivity
as high as 95% in patients with negative abdominal
ultrasonography but in whom there is a strong clinical
suspicious of gallstone diseases.66,69 The EUS-based
approach reduces the number of  unnecessary ERCP
procedures and cost-effective.70,71 EUS can be also
used for guiding fine needle  aspiration in the diagnoses
of pancreatic cancer.72
An unique imaging modality, intraductal
ultrasonography (IDUS), is suitable for a narrow
ductal cavity, its wall and the neighboring structures.
It has a very high image quality within approximately
2 cm range of radius because it uses high-frequency
ultrasonography (12-30MHz).73 Thus, IDUS may
provide good assessment for the bile duct and
pancreatic duct. In the same session as ERCP,
biliopancreatic IDUS is usually performed through the
papilla of Vater; whereas biliary IDUS may be also
performed through the percutaneous transhepatic
route.
The addition of EUS-guided fine needle aspiration
(FNA) has improved the ability to detect and staging
the benign and malignant lesions in the gastrointestinal
tract by obtaining tissue for histologic diagnosis.74
CONCLUSION
Imaging of the biliary tract is very important in
the investigation and diagnoses of biliary tract disease.
There are many options in the field of biliary imaging
and abdominal ultrasonography will guide to choose
the more sophisticated examination. It is the imaging
method of choice in the initial evaluation of all suspected
gallbladder and biliary duct diseases. Oral cholecysto-
graphy and biliary scintigraphy had been left behind.
In patients with dilated bile duct on ultrasonography
examination, the next step will be ERCP/MRCP/PTC/
CT scan. We should choose the right options, one or
two options ,not too much because it is highly cost and
may result in confusion if too much options are
chosen.
The combination of history of the disease, physical
findings, biochemical tests, abdominal US will guide
us to choose the more exact and more sophisticated
examination to uncover the exact cause of the
disease.
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